Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Sunitinib Impurity 57

Sunitinib Impurity 57 is listed in the pharmaceutical impurity collection under CAS 2365-44-8. Its represented structure has formula C8H7N3O and a calculated molecular weight of 161.16 g/mol.

2D chemical structure

H N N H O N H

Chemical identity

Catalog name
Sunitinib Impurity 57
Common name
Sunitinib Impurity 57
Chemical name
3-diazenyl-1H-indol-2-ol
CAS
2365-44-8
SMILES
N=Nc1c(O)[nH]c2ccccc12
InChI
InChI=1S/C8H7N3O/c9-11-7-5-3-1-2-4-6(5)10-8(7)12/h1-4,9-10,12H
InChIKey
KWSQYVPIKHBAQV-UHFFFAOYSA-N
Associated API
Sunitinib

Record ID: A5416fe3237d9

Computed properties

C8H7N3O Molecular formula
161.164 g/molMolecular weight
161.0589 DaMonoisotopic exact mass
72.23 ŲTopological polar surface area
2.536 Calculated LogP (Wildman–Crippen)
44.7712 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 2 4 6 8 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight161.1648.06
Calculated LogP (Wildman–Crippen)2.53652.88
Topological polar surface area72.2351.43
Hydrogen-bond acceptors333.13
Hydrogen-bond donors381.39
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC8H7N3Odimensionless
Molecular weight161.164g/mol
Monoisotopic exact mass161.0589Da
Topological polar surface area72.23Ų
Calculated LogP (Wildman–Crippen)2.536dimensionless
Molar refractivity (Wildman–Crippen)44.7712cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors3count
Rotatable bonds (strict)1count
Heavy atoms12count
Heteroatoms4count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area68.3533Ų
Valence electrons60count
Radical electrons0count
Bertz complexity432.7956index
Balaban J2.8995index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Sunitinib Impurity 57

Qualification and safety assessment of Sunitinib Impurity 57

Explore toxicological qualification of Sunitinib Impurity 57 and ICH M7 mutagenic impurity assessment of Sunitinib Impurity 57 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Sunitinib Impurity 57 and acceptable intake and limit justification for Sunitinib Impurity 57. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Sunitinib Impurity 57

Explore Altox services and software through the Altox Pharma-Hub.